Ikarian Capital »

Sionna Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 108k 43.99

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
Viking Global Investors
Atlas Venture Life Science Advisors
OrbiMed Advisors
Enavate Sciences GP
Adage Capital Partners GP
Jpmorgan Chase & Co
BlackRock
Jennison Associates
Citadel Advisors
Vanguard Capital Management
Perceptive Advisors
T. Rowe Price Associates
State Street Corporation

View all funds holding Sionna Therapeutics